The largest database of trusted experimental protocols

5 protocols using pcmv neo bam p53 r248w

1

Characterization of Mutant p53 Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
RPMI1640 medium, Opti-modified Eagle’s medium (Opti-MEM), fetal bovine serum (FBS), penicillin, and streptomycin were purchased from Life Technologies, Inc. (Grand Island, NY, USA). Dimethyl sulfoxide (DMSO), RNase A, leupeptin, aprotinin, phenylmethylsulfonylfluoride, and Triton X-100 were purchased from Sigma-Aldrich Co. (St Louis, MO, USA). The pCMV-Neo-Bam p53-R175H, pCMV-Neo-Bam p53-R248W, pCMV-Neo-Bam p53-R273H, and pCMV-Neo-Bam p53 wild-type were obtained from Addgene (Cambridge, MA, USA). The antibodies against anti-p53, anti-Rad21, anti-S1PR1, anti-THBS1, and anti-β-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The protein G PLUS-agarose was also obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
+ Open protocol
+ Expand
2

Generation and Validation of Mutant p53 MV4;11 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
AML-193 (CRL-9589), MV4;11 (CRL-9591) and THP-1 (TIB-202) cells were obtained from American Type Culture Collection (ATCC), (Manassas, VA). THP-1 cells were cultured in RPMI culture medium supplemented with 10% fetal bovine serum (FBS), 2 mM/L L-glutamine, 25 U/mL penicillin, and 25 μg/mL streptomycin. MV4;11 cells were cultured in IMDM culture medium with supplements listed above. AML-193 cells were cultured in IMDM with 5% FBS, 0.5 ng/ml insulin, 5 ng/ml transferrin receptor and 5 ng/ml GM-CSF.
For generation of MV4;11 cells expressing mutant p53, pCMV-Neo-Bam p53 R248W (Addgene plasmid # 16437), a gift from Bert Vogelstein [11 (link)] was used. MV4;11 cells (2.5 × 106) were transfected by nucleofection using Amaxa Nucleofector (Lonza, Basel, Switzerland), Kit V, program A-030. Transfected clones were isolated by single cell dilution cloning and antibiotic selection (500 μg/ml G418), followed by screening by immunoblotting.
+ Open protocol
+ Expand
3

Plasmid Construction and Genomic Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
A plasmid bearing the p53 R248W mutation (pCMV-Neo-Bam p53 R248W) was purchased from Addgene (Cambridge, MA, USA). The open reading frame was cloned into the pEF vector97 (link) along with a FLAG epitope. The pEF-FLAG-MBP plasmid was previously described43 (link). The following oligonucleotide pairs were annealed and ligated into BsmB1-cut pFgh1tUTG98 (link).
ATM exon 2: 5′-TCCCTTGTTTCAGGATCTCGAATC-3′, 5′-AAACGATTCGAGATCCTGAAACAA-3′
TP53 exon 1: 5′-TCCCTCGACGCTAGGATCTGACTG-3′, 5′-AAACCAGTCAGATCCTAGCGTCGA-3′
PRKDC exon 1: 5′-TCCCGCCGGTCATCAACTGATCCG-3′, 5′-AAACCGGATCAGTTGATGACCGGC-3′
RAD51A exon 2: 5′-TCCCTAGCTCCTTCTTTGGCGCAT-3′, 5′-AAACATGCGCCAAAGAAGGAGCTA-3′
+ Open protocol
+ Expand
4

Assessing p53 mutant protein expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression studies were approved by the Keele genetic modifications of microorganisms committee. SkOv-3 cells (32,000 cells per well of a 24 well plate) were transfected with 0.1 μg CMV-Neo-Bam (vector), pCMV-Neo-Bam p53 wt, pCMV-Neo-Bam p53 R175H, pCMV-Neo-Bam p53 R273H, pCMV-Neo-Bam p53 R248W (Addgene) and 0.2 μL of Lipofectamine 2000 as previously described47 (link). Protein expression was measured by immunoblotting.
+ Open protocol
+ Expand
5

Integrin β4-Mediated Signaling in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
RPMI 1640 medium, foetal bovine serum (FBS), penicillin, and streptomycin were obtained from Life Technologies Inc. (Grand Island, NY, USA). Dimethyl sulfoxide (DMSO), RNase A, leupeptin, aprotinin, phenylmethylsulfonylfluoride, selective FAK inhibitor 14 (1,2,4,5-benzenetetramine tetrahydrochloride), and Triton X-100 were purchased from Sigma–Aldrich Co. (St Louis, MO, USA). The pCMV-Neo-Bam p53 R248W, pCMV-Neo-Bam p53 R273H, and pCMV-Neo-Bam p53 wild-type were obtained from Addgene (Cambridge, MA). CellTrackerTM was obtained from Invitrogen (Grand Island, NY, USA). The antibodies anti-p53 (DO-1, sc-126), anti-Akt, anti-focal adhesion kinase (FAK), integrin β4, and anti-β-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The antibodies anti-phospho-Akt and anti-phospho-FAK were purchased from Cell Signalling Technology (Beverly, MA, USA). Function-blocking antibody against the human integrin β4 was obtained from EMD Millipore (Billerica, MA, USA)53 (link). The PI3K/Akt inhibitor LY294002 and wortmannin were obtained from Calbiochem (San Diego, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!